Wells Fargo shares surged 3% after the Federal Reserve lifted its asset growth restriction, a key penalty from a 2018 enforcement action. The decision marks a major regulatory milestone, signaling the bank's successful progress in strengthening its risk management and governance practices.
The asset cap was initially imposed due to significant shortcomings in Wells Fargo’s internal controls and risk oversight, particularly concerning its compliance and operational risk frameworks. The restriction prevented the bank from growing its balance sheet beyond its 2017 year-end asset level until it met specific regulatory demands.
The Fed’s announcement followed an extensive review of Wells Fargo’s governance reforms and internal systems. Under the oversight of the Federal Reserve Board and the Director of Supervision and Regulation, Wells Fargo underwent rigorous evaluations and an independent third-party review. These assessments concluded that the bank had met the conditions outlined in the 2018 Consent Order related to governance and risk management improvements.
Effective May 30, 2025, the Fed formally removed the asset growth limitation. However, some other aspects of the enforcement action remain in place until the bank fully satisfies all remaining requirements.
This development gives Wells Fargo renewed capacity to expand its asset base and pursue growth strategies previously on hold. Market analysts see this as a turning point, boosting investor confidence and reflecting positively on the bank’s ability to comply with regulatory standards.
With greater operational flexibility and improved internal controls, Wells Fargo is now better positioned to compete with its peers in the U.S. banking sector. The market’s reaction confirms the significance of the Federal Reserve’s decision in shaping the bank’s future trajectory and restoring trust among investors.


noyb Files GDPR Complaints Against TikTok, Grindr, and AppsFlyer Over Alleged Illegal Data Tracking.
Sanofi’s Efdoralprin Alfa Gains EMA Orphan Status for Rare Lung Disease
Robinhood Expands Sports Event Contracts With Player Performance Wagers
California Jury Awards $40 Million in Johnson & Johnson Talc Cancer Lawsuit
Fortescue Expands Copper Portfolio With Full Takeover of Alta Copper
Treasury Wine Estates Shares Plunge on Earnings Warning Amid U.S. and China Weakness
EU Signals Major Shift on 2035 Combustion Engine Ban Amid Auto Industry Pressure
Shell M&A Chief Exits After BP Takeover Proposal Rejected
Trump Sues BBC for Defamation Over Edited Capitol Riot Speech Clip
Blackstone Leads $400 Million Funding Round in Cyera at $9 Billion Valuation
Nomura Expands Alternative Assets Strategy With Focus on Private Debt Acquisitions
FAA Unveils Flight Plan 2026 to Strengthen Aviation Safety and Workforce Development
Korea Zinc to Build $7.4 Billion Critical Minerals Refinery in Tennessee With U.S. Government Backing
MetaX IPO Soars as China’s AI Chip Stocks Ignite Investor Frenzy
Nvidia Weighs Expanding H200 AI Chip Production as China Demand Surges
United Airlines Tokyo-Bound Flight Returns to Dulles After Engine Failure
FDA Says No Black Box Warning Planned for COVID-19 Vaccines Despite Safety Debate 



